According to GlobalData’s medical device pipeline database, ten Assisted Reproductive Technology (ART) Devices devices are in various stages of development globally. GlobalData’s report Assisted Reproductive Technology (ART) Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, eight are in active development, while the remaining four are in an inactive stage of development. There are three products in the early stages of development, and the remaining five are in the late stages of development.
Reproductive health devices are used to prevent pregnancy, diagnose and treat reproductive health conditions, and assist with fertility. They are a broad category of devices that can be used by men and women of all ages. ART refers to reproductive health procedures that treat subfertile or infertile women or men such that pregnancy is more likely achieved. Two prominent techniques analyzed in this model are in vitro fertilization (IVF) and intrauterine insemination (IUI). Assisted Reproductive Technology (ART) devices are used to help couples who are having difficulty conceiving a child. ART devices include Embryo Transfer Catheters, ART Dishes.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Assisted Reproductive Technology (ART) Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Assisted Reproductive Technology (ART) Devices devices. Overall, most of these Assisted Reproductive Technology (ART) Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Assisted Reproductive Technology (ART) Devices include Nipro, University of Oxford, University of Oxford, Autoivf, Bioceptive, Femasys, Healthcare Enterprise Group, INVO Bioscience and Memphasys.
For a complete picture of the developmental pipeline for Assisted Reproductive Technology (ART) Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
